Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated January 23, 2023, titled "Glenmark launches AKYNZEO�� I.V. in India First Fixed I.V. Antiemetic Combination for the Prevention of Chemotherapy-induced Nausea and Vomiting".